Clinical Trial: A Study of Two Approved Drugs in Patients with Osteoarthritis

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of osteoarthritis of the knee.

Condition Treatment or Intervention Phase
Osteoarthritis
 
Phase II
Phase III

MedlinePlus related topics:  Osteoarthritis

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Eligibility

Ages Eligible for Study:  40 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Osteoarthritis of the knee which requires treatment with medication for pain relief

Exclusion Criteria:

  • Any known allergy to the study drug

More Information

Study ID Numbers:  2004_070
Record last reviewed:  September 2004
Last Updated:  October 13, 2004
Record first received:  September 22, 2004
ClinicalTrials.gov Identifier:  NCT00092352
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources